Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Ruth J. Pepper
ResearcherPublications, citations & collaboration network
Ruth J. Pepper is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 81 works, 2,452 citations, an h-index of 27 and an i10-index of 37.
81
Works
2,452
Citations
27
h-index
37
i10-index
IDs:OpenAlex
How has Ruth J. Pepper's publication output changed over time?
ScholarIQpublication output · 2008–2021
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2021.
1
1
2
1
1
1
3
1
20082009201320162018201920202021
What are the most-cited papers on Ruth J. Pepper?
ScholarIQmost cited works
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Marie Condon, Damien Ashby, Ruth J. Pepper, H. Terence Cook, Jeremy Levy, Megan Griffith, Tom Cairns, Liz Lightstone
Annals of the Rheumatic Diseases. 2013453 CitationsOPEN ACCESS
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
Jingyuan Xie, Lili Liu, Nikol Mladkova, Yifu Li, Hong Ren, Weiming Wang, Zhao Cui, Li Lin, X. Hu, Xialian Yu, Jing Xu, Gang Liu, Yaşar Çalışkan, Carlo Sidore, Olivia Balderes, Raphael J. Rosen, Monica Bodria, Francesca Zanoni, Jun Y. Zhang, Priya Krithivasan, Karla Mehl, Maddalena Marasà, Atlas Khan, Fatih Ozay, Pietro A. Canetta, Andrew S. Bomback, Gerald B. Appel, Simone Sanna‐Cherchi, Matthew G. Sampson, Laura Mariani, Agnieszka Perkowska‐Ptasińska, Magdalena Durlik, Krzysztof Mucha, Barbara Moszczuk, Bartosz Foroncewicz, Leszek Pączek, Ireneusz Habura, Elisabet Ars, José Ballarín, Laila-Yasmin Mani, Bruno Vogt, Savaş Öztürk, Abdülmecit Yıldız, Nurhan Seyahi, Hakkı Arikan, Mehmet Koç, Taner Baştürk, Gonca E. Karahan, Sebahat Usta Akgül, Mehmet Şükrü Sever, Dan Zhang, Domenico Santoro, Mario Bonomini, Francesco Londrino, Loreto Gesualdo, Jana Reiterová, Vladimı́r Tesař, Claudia Izzi, Silvana Savoldi, Donatella Spotti, Carmelita Marcantoni, Piergiorgio Messa, Marco Galliani, Dario Roccatello, Simona Granata, Gianluigi Zaza, Francesca Lugani, Gian Marco Ghiggeri, Isabella Pisani, Landino Allegri, Ben Sprangers, Jin‐Ho Park, Belong Cho, Yon Su Kim, Dong Ki Kim, Hitoshi Suzuki, Antonio Amoroso, Daniel Cattran, Fernando C. Fervenza, Antonello Pani, Patrick Hamilton, Shelly Harris, Sanjana Gupta, Chris Cheshire, Stephanie Dufek, Naomi Issler, Ruth J. Pepper, John Connolly, Stephen H. Powis, Detlef Böckenhauer, Horia Stanescu, Neil Ashman, Ruth J. F. Loos, Eimear E. Kenny, Matthias Wuttke, Kai‐Uwe Eckardt, Anna Köttgen, Julia M. Hofstra, Marieke J. H. Coenen, Lambertus A. Kiemeney
Nature Communications. 2020224 CitationsOPEN ACCESS
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
Ruth J. Pepper, Megan Griffith, Cliona Kirwan, Jeremy Levy, David Taube, Charles D. Pusey, Liz Lightstone, Thomas Cairns
Nephrology Dialysis Transplantation. 2009156 CitationsOPEN ACCESS
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
Ruth J. Pepper, Margarete A. Fabre, Carlos Pavésio, G. Gaskin, Rachel Jones, David Jayne, Charles D. Pusey, Alan D. Salama
Lara D. Veeken. 2008149 CitationsOPEN ACCESS
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis
Ruth J. Pepper, Sally Hamour, Konstantia-Maria Chavele, S.K. Todd, Niels Rasmussen, Shaun Flint, Paul Lyons, Kenneth G. C. Smith, Charles D. Pusey, H. Terence Cook, Alan D. Salama
Kidney International. 2013105 CitationsOPEN ACCESS
Related on ScholarIQ
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Paper
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
Paper
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
Paper
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
Paper
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis
Paper
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis
Paper